Multiple testing and data adaptive regression: An application to HIV-1 sequence data

Statistical Applications in Genetics and Molecular Biology

Volumn 4, Issue 1, 2005, Pages

  Birkner, Merrill D ^a   Sinisi, Sandra E ^a   Van Der Laan, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bootstrap; Codon; Generalized family wise error rate; HIV 1; Multiple testing; Prediction; Tail probability of the proportion of false positives; Type I error; Variable selection

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ANALYTICAL ERROR; ARTICLE; CODON; GENE LOSS; GENE MUTATION; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC RISK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MULTIPLE REGRESSION; PREDICTION; REGRESSION ANALYSIS; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STRUCTURE ANALYSIS; VALIDATION PROCESS; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS REPLICATION;

EID: 18944374818     PISSN: 15446115     EISSN: 15446115     Source Type: Journal    
DOI: 10.2202/1544-6115.1110     Document Type: Article

References (21)

1. J. August, Ferid Murad, and Kuan-Teh Jeang, editors. HIV-1: Molecular Biology and Pathogenesis - Clinical Applications, volume 49 of Advances in Pharmacology. Academic Press, 2000.
2. Jason D. Barbour, Terri Wrin, Robert M. Grant, Jeffrey N. Martin, Mark R. Segal, Christos J. Petropoulos, and Steven G. Deeks. Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults. Journal of Virology, 76(21):11104-11112, 2002.
3. Steven G. Deeks. Treatment of Antiretroviral-drug-resistant HIV-1 Infection. The Lancet, 362:2002-2011, 2003.
4. Steven G. Deeks, Terri Wrin, Teri Liegler, Rebecca Hoh, Matthew Hayden, Jason D. Barbour, Nicholas S. Hellmann, Christos J. Petropoulos, Joseph M. McCune, Marc K. Hellerstein, and Robert M. Grant. Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral Drug Therapy in HIV-infected Patients with Detectable Viremia. New England Journal of Medicine, 344(7):472-480, 2001.
5. Sandrine Dudoit, Mark J. van der Laan, and Katherine S. Pollard. Multiple Testing. Part I. Single-Step Procedures for Control of General Type I Error Rates. Statistical Applications in Genetics and Molecular Biology, 3(1), 2004. URL http://www.bepress.com/sagmb/vol3/iss1/art13. Article 13.
6. Matthew J. Gonzales, Ilana Belitskaya, Kathryn M. Dupnik, Soo-Yon Rhee, and Robert W. Shafer. Protease and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions. AIDS Reseach and Human Retroviruses, 19(10):909-915, 2003.
7. Jaap Goudsmit, Anthony de Ronde, Ester de Rooij, and Rob de Boer. Broad Spectrum of in Vivo Fitness of Human Immunodeficiency Virus Type 1 Subpopulations Differing at Reverse Transcriptase Codons 41 and 215. Journal of Virology, 71(6):4479-4484, 1997.
8. Jonathan Karn, editor. HIV: A Practical Approach, volume 2 of Biochemistry, Molecular Biology, and Drug Discovery. Oxford University Press, 1995.
9. Javier Martinez-Picado, Anu V. Savara, Lorraine Sutton, and Richard T. D'Aquila. Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1. Journal of Virology, 73(5):3744-3752, 1999.
10. Monique Nijhuis, Steven Deeks, and Charles Boucher. Implications of Antiretroviral Resistance on Viral Fitness. Current Opinion in Infectious Diseases, 14:23-28, 2001.
11. Katherine S. Pollard and Mark J. van der Laan. Resampling-based Multiple Testing: Asymptotic Control of Type I error and Applications to Gene Expression Data. Technical Report 121, Division of Biostatistics, University of California, Berkeley, June 2003. URL http://www.bepress.com/ucbbiostat/paper121.
12. Julia G. Prado, Terri Wrin, Je Beauchaine, Lidia Ruiz, Christos J. Petropoulos, Simon D.W. Frost, Bonaventura Clotet, Richard T. D'Aquila, and Javier Martinez-Picado. Amprenavir-Resistant HIV-1 Exhibits Lopinavir Cross-Resistance and Reduced Replication Capacity. AIDS, 16 (7):1009-1017, 2002.
13. Mark R. Segal, Jason D. Barbour, and Robert M. Grant. Relating HIV-1 Sequence Variation to Replication Capacity via Trees and Forests. Statistical Applications in Genetics and Molecular Biology, 3(1), 2004. URL http://www.bepress.com/sagmb/vol3/iss1/art2. Article 2.
14. Robert W. Shafer, Mark A. Winters, Sarah Palmer, and Thomas C. Merigan. Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients. Annals of Internal Medicine, 128(11):906-911, 1998.
15. Robert W. Shafer, Kathryn M. Dupnik, Mark A. Winters, and Susan H. Eshleman. A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies. In HIV Sequencing Compendium, pages 83-133. Theoretical Biology and Biophysics Group at Los Alamos National Laboratory, 2001.
16. Sandra E. Sinisi and Mark J. van der Laan. Deletion/Substitution/Addition Algorithm in Learning with Applications in Genomics. Statistical Applications in Genetics and Molecular Biology, 3(1), 2004. URL http://www.bepress.com/sagmb/ vol3/iss1/art18. Article 18.
17. Carlos Sune, Lyndall Brennan, David R. Stover, and Thomas Klimkait. Effect of Polymorphisms on the Replication Capacity of Protease Inhibitor-Resistant HIV-1 Variants under Drug Pressure. Clinical Microbiology and Infection, 10(2):119-129, 2004.
18. Mark J. van der Laan and James M. Robins. Unified Methods for Censored Longitudinal Data and Causality. Springer Series in Statistics. Springer, 2003.
19. Mark J. van der Laan, Sandrine Dudoit, and Katherine S. Pollard. Augmentation Procedures for Control of the Generalized Family-Wise Error Rate and Tail Probabilities for the Proportion of False Positives. Statistical Applications in Genetics and Molecular Biology, 3(1), 2004. URL http://www.bepress.com/sagmb/vol3/iss1/art15. Article 15.
20. Thomas D. Wu, Celia A. Schi er, Matthew J. Gonzales, Jonathan Tyalor, Rami Kantor, Sunwen Chou, Dennis Israelski, Andrew R. Zolopa, W. Jeffrey Fessel, and Robert W. Shafer. Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatment. Journal of Virology, 77(8):4836-4847, 2003.
21. Veronique Zennou, Fabrizio Mammano, Sylvie Paulous, Dominique Mathez, and Francois Clavel. Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors in vivo. Journal of Virology, 72(4):3300-3306, 1998.